Shuyan Chen

613 total citations
29 papers, 235 citations indexed

About

Shuyan Chen is a scholar working on Epidemiology, Hepatology and Cognitive Neuroscience. According to data from OpenAlex, Shuyan Chen has authored 29 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 17 papers in Hepatology and 3 papers in Cognitive Neuroscience. Recurrent topics in Shuyan Chen's work include Liver Disease Diagnosis and Treatment (16 papers), Hepatitis B Virus Studies (15 papers) and Hepatitis C virus research (11 papers). Shuyan Chen is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Hepatitis B Virus Studies (15 papers) and Hepatitis C virus research (11 papers). Shuyan Chen collaborates with scholars based in China, United States and Singapore. Shuyan Chen's co-authors include Yameng Sun, Hong You, Xiaoning Wu, Xiaojuan Ou, Jialing Zhou, Jidong Jia, Bingqiong Wang, Shanshan Wu, Yuanyuan Kong and Xinyan Zhao and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Shuyan Chen

25 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuyan Chen China 9 157 152 19 18 17 29 235
Huanming Xiao China 9 174 1.1× 139 0.9× 16 0.8× 15 0.8× 34 2.0× 24 222
V. Ozenne France 3 125 0.8× 174 1.1× 29 1.5× 22 1.2× 16 0.9× 4 194
Berta Caballol Spain 6 176 1.1× 140 0.9× 10 0.5× 34 1.9× 25 1.5× 18 234
Maria Tampaki Greece 7 94 0.6× 111 0.7× 8 0.4× 15 0.8× 24 1.4× 15 168
Manon Allaire France 7 65 0.4× 93 0.6× 15 0.8× 25 1.4× 15 0.9× 14 132
Fabienne Drane France 4 250 1.6× 204 1.3× 8 0.4× 25 1.4× 13 0.8× 5 286
Emily Zhang United States 4 209 1.3× 210 1.4× 12 0.6× 22 1.2× 28 1.6× 5 280
Xieer Liang China 12 277 1.8× 229 1.5× 7 0.4× 24 1.3× 23 1.4× 32 312
Anne Linde Mak Netherlands 8 152 1.0× 82 0.5× 15 0.8× 26 1.4× 57 3.4× 13 210
Bingqiong Wang China 9 204 1.3× 193 1.3× 4 0.2× 16 0.9× 22 1.3× 23 247

Countries citing papers authored by Shuyan Chen

Since Specialization
Citations

This map shows the geographic impact of Shuyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyan Chen more than expected).

Fields of papers citing papers by Shuyan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyan Chen. The network helps show where Shuyan Chen may publish in the future.

Co-authorship network of co-authors of Shuyan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shuyan Chen. A scholar is included among the top collaborators of Shuyan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuyan Chen. Shuyan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Zhiying, Zhongjie Hu, Chunqing Zhang, et al.. (2025). Unstable Recompensation: An Intermediate Subtype in Patients With HBV ‐Related Decompensated Cirrhosis. Alimentary Pharmacology & Therapeutics. 63(5). 715–727. 2 indexed citations
2.
Zhang, Mengyang, Shuyan Chen, Xiaoning Wu, et al.. (2025). Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment. Nature Communications. 16(1). 7714–7714.
3.
Ma, Yongfeng, et al.. (2024). Socioeconomic and travel factors that affect perceptions of visually impaired persons regarding crosswalk tactile paving. Travel Behaviour and Society. 36. 100811–100811. 1 indexed citations
4.
Chen, Shuyan, Jialing Zhou, Xiaoning Wu, et al.. (2024). Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments. Hepatology International. 18(3). 904–916. 3 indexed citations
5.
Wen, Xiajie, Xiaoning Wu, Yameng Sun, et al.. (2024). Long‐term antiviral therapy is associated with changes in the profile of transcriptionally active HBV integration in the livers of patients with CHB. Journal of Medical Virology. 96(6). e29606–e29606. 3 indexed citations
6.
Sun, Yameng, Shuyan Chen, Bingqiong Wang, et al.. (2024). Multiple Low‐Level Viraemia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients During Antiviral Therapy. Journal of Viral Hepatitis. 31(12). 898–902. 1 indexed citations
7.
Chen, Wei, et al.. (2023). Pipeline for precise insoluble matrisome coverage in tissue extracellular matrices. Frontiers in Bioengineering and Biotechnology. 11. 1135936–1135936. 2 indexed citations
8.
Chen, Wei, Yameng Sun, Shuyan Chen, et al.. (2023). Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities. Hepatology. 78(4). 1118–1132. 15 indexed citations
9.
Wu, Xiaoning, Jialing Zhou, Yameng Sun, et al.. (2023). Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients. Clinical and Molecular Hepatology. 29(3). 747–762. 6 indexed citations
10.
11.
Chen, Shuyan, Bingqiong Wang, Jialing Zhou, et al.. (2023). A new glutamine synthetase index to evaluate hepatic lobular restoration in advanced fibrosis during anti‐HBV therapy. Journal of Medical Virology. 95(2). e28555–e28555.
12.
Zhao, Xinyu, Min� Li, Hao Wang, et al.. (2022). Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China. Journal of Clinical and Translational Hepatology. 10(3). 420–428. 6 indexed citations
13.
Wu, Xiaoning, Jialing Zhou, Yameng Sun, et al.. (2021). Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis. Hepatology International. 15(6). 1318–1327. 11 indexed citations
14.
Ma, Yongfeng, et al.. (2021). Evaluating the effectiveness of crosswalk tactile paving on street-crossing behavior: A field trial study for people with visual impairment. Accident Analysis & Prevention. 163. 106420–106420. 6 indexed citations
15.
Sun, Yameng, Xiaoning Wu, Jialing Zhou, et al.. (2020). Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy. Clinical Gastroenterology and Hepatology. 18(11). 2582–2591.e6. 72 indexed citations
16.
Sun, Yameng, Shuyan Chen, & Hong You. (2020). Regression of liver fibrosis: evidence and challenges. Chinese Medical Journal. 133(14). 1696–1702. 26 indexed citations
17.
Wang, Bingqiong, Yameng Sun, Jialing Zhou, et al.. (2019). SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies. Hepatology International. 13(4). 501–509. 11 indexed citations
18.
Wang, Bingqiong, Yameng Sun, Jialing Zhou, et al.. (2018). Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients. Modern Pathology. 31(10). 1567–1577. 14 indexed citations
19.
Chen, Shuyan, Lihua Yao, & Timothy J. Cunningham. (2012). Secreted Phospholipase A2 Involvement in Neurodegeneration: Differential Testing of Prosurvival and Anti-Inflammatory Effects of Enzyme Inhibition. PLoS ONE. 7(6). e39257–e39257. 11 indexed citations
20.
Chen, Shuyan, et al.. (2011). Effect of aerobic exercise on patients with laryngeal cancer related fatigue status. Zhonghua xiandai huli zazhi. 17(16). 1905–1907. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huanming Xiao Breakdown of academic impact, for papers by V. Ozenne Breakdown of academic impact, for papers by Berta Caballol Breakdown of academic impact, for papers by Maria Tampaki Breakdown of academic impact, for papers by Manon Allaire Breakdown of academic impact, for papers by Fabienne Drane Breakdown of academic impact, for papers by Emily Zhang Breakdown of academic impact, for papers by Xieer Liang Breakdown of academic impact, for papers by Anne Linde Mak Breakdown of academic impact, for papers by Bingqiong Wang
Rankless by CCL
2026